Registry Intervention View

Lampalizumab

Trial registrations containing the exact intervention label Lampalizumab.

Exact registry label · Not reported

3 linked registrations

No aliases or equivalent products have been inferred.

Longevity context

Topics connected by trial metadata

Vision ageing3 trials

Safety context

3 linked registrations report posted results

This is a registry availability fact, not a safety result, comparison, or conclusion.

Understand the safety boundary →

Source records

Registered trials

TerminatedNCT02247531

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

PHASE3 · 975 planned enrolment

Countries listed: 22
Registry update: October 15, 2019

Verify in the registry →

TerminatedNCT02247479

A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

PHASE3 · 906 planned enrolment

Countries listed: 19
Registry update: June 26, 2019

Verify in the registry →

TerminatedNCT02745119

Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)

PHASE3 · 994 planned enrolment

Countries listed: 19
Registry update: March 6, 2019

Verify in the registry →